Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleSafety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study)
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsJing Wang